A Randomized Trial to Evaluate OnabotulinumtoxinA for Prevention of Headaches in Adolescents With Chronic Migraine

Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition

(2018)   CEPHALALGIA

Onabotulinumtoxin A (BOTOX®) for ProphylaCTIC Treatment of Pediatric Migraine: A Retrospective Longitudinal Analysis

(2018) Shalini Shah et al.   JOURNAL OF CHILD NEUROLOGY

Long-term study of the efficacy and safety of OnabotulinumtoxinA for the prevention of chronic migraine: COMPEL study

(2018) Andrew M. Blumenfeld et al.   JOURNAL OF HEADACHE AND PAIN

Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

(2017) Theo Vos et al.   LANCET

Trial of Amitriptyline, Topiramate, and Placebo for Pediatric Migraine

(2017) Scott W. Powers et al.   NEW ENGLAND JOURNAL OF MEDICINE

Chronic Migraine in Children and Adolescents

(2016) Aynur Özge et al.   Current Pain and Headache Reports

Oral Triptans in Children and Adolescents: An Update

(2015) Fumihiko Sakai   Current Pain and Headache Reports

Preventive Drugs in Childhood and Adolescent Migraine

(2014) Joanne Kacperski et al.   Current Pain and Headache Reports

Per cent of patients with chronic migraine who responded per onabotulinumtoxinA treatment cycle: PREEMPT

(2014) Stephen D Silberstein et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Harnessing the Placebo Effect in Pediatric Migraine Clinic

(2014) Vanda Faria et al.   JOURNAL OF PEDIATRICS

Off-Label Use of Drugs in Children

(2014) et al.   PEDIATRICS

The Efficacy of Triptans in Childhood and Adolescence Migraine

(2013) Stefan Evers   Current Pain and Headache Reports

Placebo effects in children: a review

(2013) Katja Weimer et al.   PEDIATRIC RESEARCH

Migraine Therapeutics in Adolescents

(2013) Haihao Sun et al.   JAMA Pediatrics

Pharmacologic Treatment of Pediatric Headaches

(2013) Khalil El-Chammas et al.   JAMA Pediatrics

Efficacy and tolerability of rizatriptan in pediatric migraineurs: Results from a randomized, double-blind, placebo-controlled trial using a novel adaptive enrichment design

(2012) Tony W Ho et al.   CEPHALALGIA

OnabotulinumtoxinA in Pediatric Chronic Daily Headache

(2012) Marielle Kabbouche et al.   Current Neurology and Neuroscience Reports

Chronic Migraine Prevalence, Disability, and Sociodemographic Factors: Results From the American Migraine Prevalence and Prevention Study

(2012) Dawn C. Buse et al.   HEADACHE

Ten-Year Follow-Up in a Case Series of Integrative Botulinum Toxin Intervention in Adolescents with Chronic Daily Headache and Associated Muscle Pain

(2012) A. Schroeder et al.   NEUROPEDIATRICS

Prevalence and Burden of Chronic Migraine in Adolescents: Results of the Chronic Daily Headache in Adolescents Study (C-dAS)

(2011) Richard B. Lipton et al.   HEADACHE

OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Analyses of the 56-Week PREEMPT Clinical Program

(2011) Sheena K. Aurora et al.   HEADACHE

Investigating dose-dependent effects of placebo analgesia: A psychophysiological approach

(2011) Yoshio Nakamura et al.   PAIN

Prevalence of headache and migraine in children and adolescents: a systematic review of population-based studies

(2010) ISHAQ ABU-ARAFEH et al.   DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY

Method of Injection of OnabotulinumtoxinA for Chronic Migraine: A Safe, Well-Tolerated, and Effective Treatment Paradigm Based on the PREEMPT Clinical Program

(2010) Andrew Blumenfeld et al.   HEADACHE

OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double-Blind, Randomized, Placebo-Controlled Phases of the PREEMPT Clinical Program

(2010) David W. Dodick et al.   HEADACHE

Does Inclusion of a Placebo Arm Influence Response to Active Antidepressant Treatment in Randomized Controlled Trials?

(2010) Mark Sinyor et al.   JOURNAL OF CLINICAL PSYCHIATRY

Experience With Botulinum Toxin Type A in Medically Intractable Pediatric Chronic Daily Headache

(2010) Karman Ahmed et al.   PEDIATRIC NEUROLOGY

Analysis of the Relationship Between Age and Treatment Response in Migraine

(2009) HJ Maas et al.   CEPHALALGIA

Botox Treatment for Migraine and Chronic Daily Headache in Adolescents

(2009) Valerie W. Chan et al.   JOURNAL OF NEUROSCIENCE NURSING

Does Study Design Influence Outcome?

(2009) Bret R. Rutherford et al.   PSYCHOTHERAPY AND PSYCHOSOMATICS

Placebo Efficacy in Childhood and Adolescence Migraine: An Analysis of Double-Blind and Placebo-Controlled Studies

(2008) S Evers et al.   CEPHALALGIA

Does the probability of receiving placebo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDD

(2008) George I. Papakostas et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Cutaneous allodynia in the migraine population

(2007) Richard B. Lipton et al.   ANNALS OF NEUROLOGY